Thyroid Functioning in Diabetes Mellitus Complicated with Chronic Renal Disease

Main Article Content

Ye.G. Sazonova
T.V. Mokhort

Abstract

Thyroid hormones affect renal physiological development, kidney structure, renal hemodynamics, glomerular filtration rate, the function of a number of nephron transport systems, and water-electrolyte metabolism. These influences of thyroid hormones are realized through direct and pre-renal effects. Chronic kidney disease can induce clinically apparent metabolic changes in thyroid hormones. This review focuses on the important and clinically relevant interactions between thyroid function and renal one, which are essential for the clinician to optimally manage the patient.

Article Details

How to Cite
Sazonova, Y., and T. Mokhort. “Thyroid Functioning in Diabetes Mellitus Complicated With Chronic Renal Disease”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 2.50, Feb. 2013, pp. 62-67, doi:10.22141/2224-0721.2.50.2013.84283.
Section
Literature Review

References

Kaptein E.M. Thyroid function in renal failure // Contrib. Nephrol. — 1986. — Vol. 50. — P. 64-72.

Kaptein E.M., Feinstein E.I., Massry S.G. Thyroid hormone metabolism in renal diseases // Contrib. Nephrol. — 1982. — Vol. 33. — P. 122-135.

Kaptein E.M., Quion-Verde H., Massry S.G. Hemodynamic effects of thyroid hormone // Contrib. Nephrol. — 1984. — Vol. 41. — P. 151-159.

Lim V.S., Passo C., Murata Y. et al. Reduced triiodothyronine content in liver but not pituitary of the uremic rat model: Demonstration of changes compatible with thyroid hormone deficiency in liver only // Endocrinology. — 1984. — Vol. 114. — P. 280-286.

Katz A.I., Lindheimer M.D. Actions of hormones on the kidney // Annual Review of Physiology. — 1977. — Vol. 39. — P. 97-133.

Katz A.I., Emmanouel D.S., Lindheimer M.D. Thyroid hormone and the kidney // Nephron. — 1975. — Vol. 15. — P. 223-249.

Kaptein E.M., Quion-Verde H., Chooljian C.J. et al. The thyroid in end-stage renal disease // Medicine. — 1988. — Vol. 67. — P. 187-197.

Davis R.G., Madsen K.M., Fregly M.J., Tisher C.C. Kidney structure in hypothyroidism // Am. J. Pathol. — 1983. — Vol. 113. — P. 41-49.

Slotkin T.A., Seidler F.J., Kavlock R.J., Bartolome J.V. Thyroid hormone differentially regulates cellular development in neonatal rat heart and kidney // Teratology. — 1999. — Vol. 45. — P. 303-312.

Canavan J.P., Holt J., Easton J. et al. Thyroid-induced changes in the growth of the liver, kidney, and diaphragm of neonatal rats // J. Cell. Physiol. — 1994. — Vol. 161. — P. 49-54.

Li X., Misik A.J., Rieder C.V. et al. Thyroid hormone receptor alpha 1 regulates expression of the Na+/H+exchanger (NHE1) // J. Biol. Chem. — 2002. — Vol. 277. — P. 28656-28662.

Emmanouel D.S., Lindheimer M.D., Katz A.I. Mechanism of impaired water excretion in the hypothyroid rat // J. Clin. Invest. — 1974. — Vol. 54. — P. 926-934.

Lin H.H., Tang M.J. Thyroid hormone upregulates

Na-K-ATPase alpha and beta mRNA in primary cultures of proximal tubule cells // Life Sci. — 1997. — Vol. 60. — P. 375-382.

Katz A.I., Lindheimer M.D. Renal sodium- and potassium-activated adenosine triphosphatase and sodium reabsorption in the hypothyroid rat // J. Clin. Invest. — 1973. — Vol. 52. — P. 796-804.

McCaffrey C., Quamme G.A. Effects of thyroid status on renal calcium and magnesium handling // Can. J. Comp. Med. — 1984. — Vol. 48. — P. 51-57.

Del Compare J.A., Aguirre J.A., Ibarra F.R. et al. Effects of thyroid hormone on the renal dopaminergic system // Endocrine. — 2001. — Vol. 15. — P. 297-303.

Pracyk J.B., Slotkin T.A. Thyroid hormone differentially regulates development of beta-adrenergic receptors, adenylatecyclase and ornithine decarboxylase in rat heart and kidney // J. Dev. Physiol. — 1991. — Vol. 16. — P. 251-261.

Vaamonde C.A., Sebastianelli M.J., Vaamonde L.S. et al. Impaired renal tubular reabsorption of sodium in hypothyroid man // J. Lab. Clin. Med. — 1975. — Vol. 85. — P. 451-466.

Segarra A.B., Ramirez M., Banegas I. et al. Influence of thyroid disorders on kidney angiotensinase activity // Horm. Metab. Res. — 2006. — Vol. 38. — P. 48-52.

Hollander J.G., Wulkan R.W., Mantel M.J., Berghout A. Correlation between severity of thyroid dysfunction and renal function // Clin. Endocrinol (Oxf). — 2005. — Vol. 62. — P. 423-427.

Crowley W.F., Ridgway E.C., Bough E.W. et al. Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement // N. Engl. J. Med. — 1977. — Vol. 296. — P. 1-6.

Klein I., Danzi S. Thyroid disease and the heart // Circulation. — 2007. — Vol. 116. — P. 1725-1735.

Diekman M.J., Harms M.P., Endert E. et al. Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients // Eur. J. Endocrinol. — 2001. — Vol. 144. — P. 339-346.

Singer M.A. Of mice and men and elephants: Metabolic rate sets glomerular filtration rate // Am. J. Kidney Dis. — 2001. — Vol. 37. — P. 164-178.

Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system // N. Engl. J. Med. — 2001. — Vol. 344. — P. 501-509.

Schmid C., Brandle M., Zwimpfer C. et al. Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor // Clin. Chem. — 2004. — Vol. 50. — P. 228-231.

Bradley S.E., Coelho J.B., Sealey J.E. et al. Changes in glomerulo-tubular dimensions, single nephron glomerular filtration rates and the renin-angiotensin system in hypothyroid rats // Life Sci. — 1982. — Vol. 30. — P. 633-639.

Montenegro J., Gonzalez O., Saracho R. et al. Changes in renal function in primary hypothyroidism // Am. J. Kidney Dis. — 1996. — Vol. 27. — P. 195-198.

Vargas F., Moreno J.M., Rodriguez-Gomez I. et al. Vascular and renal function in experimental thyroid disorders // Eur. J. Endocrinol. — 2006. — Vol. 154. — P. 197-212.

Asmah B.J., Wan Nazaimoon W.M., Norazmi K. et al. Plasma renin and aldosterone in thyroid diseases // Horm. Metab. Res. — 1997. — Vol. 29. — P. 580-583.

Zimmerman R.S., Ryan J., Edwards B.S. et al. Cardiorenal endocrine dynamics during volume expansion in hypothyroid dogs // Am. J. Physiol. — 1988. — Vol. 255. — P. 61-66.

Garg L.C., Tisher C.C. Effects of thyroid hormone on Na-K-adenosine triphosphatase activity along the rat nephron // J. Lab. Clin. Med. — 1985. — Vol. 106. — P. 568-572.

Michael U.F., Barenberg R.L., Chavez R. et al. Renal handling of sodium and water in the hypothyroid rat. Clearance and micropuncture studies // J. Clin. Invest. — 1972. — Vol. 51. — P. 1405-1412.

Derubertis F.R., Michelis M.F., Bloom M.E. et al. Impaired water excretion in myxedema // Am. J. Med. — 1971. — Vol. 51. — P. 41-53.

Hanna F.W., Scanlon M.F. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin // Lancet. — 1997. — Vol. 350. — P. 755-756.

Manetti L., Pardini E., Genovesi M. et al. Thyroid function differently affects serum cystatin C and creatinine concentrations // J. Endocrinol. Invest. — 2005. — Vol. 28. — P. 346-349.

Wheatley T., Edwards O.M. Mild hypothyroidism and oedema: Evidence for increased capillary permeability to protein // Clin. Endocrinol (Oxf). — 1983. — Vol. 18. — P. 627-635.

Suher M., Koc E., Ata N., Ensari C. Relation of thyroid disfunction, thyroid autoantibodies, and renal function // Ren. Fail. — 2005. — Vol. 27. — P. 739-742.

Fricker M., Wiesli P., Brandle M. et al. Impact of thyroid dysfunction on serum cystatin C // Kidney Int. — 2003. — Vol. 63. — P. 1944-1947.

Goede D.L., Wiesli P., Brandle M. et al. Effects of thyroxine replacement onserum creatinine and cystatin C in patients with primary and central hypothyroidism // Swiss Med. — 2009. — Vol. 139. — P. 339-344.

Kimmel M., Braun N., Alscher M. Influence of thyroid function on different kidney function tests // Kidney Blood Press. Res. — 2012. — Vol. 35. — P. 9-17.

Mariani L.H., Berns J.S. The Renal Manifestations of Thyroid Disease // J. Am. Soc. Nephrol. — 2012. — Vol. 23. — P. 22-26.

Basu G., Mohapatra A. Interactions between thyroid disorders and kidney disease // Indian J. Endocrinol. Metab. — 2012. — Vol. 16 (2). — P. 204-213.

Wijkhuisen A., Djouadi F., Vilar J. et al. Thyroid hormones regulate development of energy metabolism enzymes in rat proximal convoluted tubule // Am. J. Physiol. — 1995. — Vol. 268. — P. 634-642.

Kaptein E.M. Thyroid hormone metabolism and thyroid diseases in chronic renal failure // Endocrine Reviews. — 1996. — Vol. 17. — P. 45-63.

Ross R.J., Goodwin F.J., Houghton B.J., Boucher B.J. Alteration of pituitary-thyroid function in patients with chronic renal failure treated by haemodialysis or continuous ambulatory peritoneal dialysis // Ann. Clin. Biochem. — 1985. — Vol. 22. — P. 156-160.

Gomez-Pan A., Alvarez-Ude F., Yeo P.P. et al. Function of the hypothalamo-hypophysial-thyroid axis in chronic renal failure // Clin. Endocrinol (Oxf). — 1979. — Vol. 11 (5). — P. 567-574.

Hegedus L., Andersen J.R., Poulsen L.R. et al. Thyroid gland volume and serum concentrations of thyroid hormones in chronic renal failure // Nephron. — 1985. — Vol. 40. — P. 171-174.

Miki H., Oshimo K., Inoue H. et al. Thyroid carcinoma in patients with secondary hyperparathyroidism // J. Surg. Oncol. — 1992. — Vol. 49. — P. 168-171.

Meuwese C.L., Dekker F.W., Lindholm B. et al. Baseline Levels and Trimestral Variation of Triiodothyronine and Thyroxine and Their Association with Mortality in Maintenance Hemodialysis Patients // Clin. J. Am. Soc. Nephrol. — 2012. — Vol. 7. — P. 131-138.

Lo J.C., Chertow G.M., Go A.S., Hsu C.Y. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease // Kidney Int. — 2005. — Vol. 67. — P. 1047-1052.

Chonchol M., Lippi G., Salvagno G. et al. Prevalence of Subclinical Hypothyroidism in Patients with Chronic Kidney Disease // Clin. J. Am. Soc. Nephrol. — 2008. — Vol. 3. — P. 1296-1300.

Bando Y., Ushiogi Y., Okafuji K. et al. Non-autoimmune primary hypothyroidism in diabetic and non-diabetic chronic renal dysfunction // Exp. Clin. Endocrinol. Diabetes. — 2002. — Vol. 110 (8). — P. 408-415.

Chen H.S., Wu T.E., Jap T.S. et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients // Diabet. Med. — 2007. — Vol. 24(12). — P. 1336-1344.

Iglesias P., Diez J.J. Thyroid dysfunction and kidney disease // Eur. J. Endocrinol. — 2009. — Vol. 160. — P. 503-515.

Zoccali C., Tripepi G., Cutrupi S. et al. Low triiodothyronine: A new facet of inflammation in end-stage renal disease // J. Am. Soc. Nephrol. — 2005. — Vol. 16. — P. 2789-2795.

Kaptein E.M., Feinstein E.I., Nicoloff J.T., Massry S.G. Serum reversе triiodothyronine and thyroxine kinetics in patients with chronic renal failure // J. Clin. Endocrinol. Metab. — 1983. — Vol. 57. — P. 181-189.

Ramirez G., O’Neill W., Jubiz W., Bloomer H.A. Thyroid dysfunction in uremia: Evidence for thyroid and hypophyseal abnormalities // Ann. Intern. Med. — 1976. — Vol. 84. — P. 672-676.

Lim V.S., Fang V.S., Katz A.I., Refetoff S. Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine // Journal of Clinical Investigation. — 1977. — Vol. 60. — P. 522-534.

Alvarez-Ude F., Gomez-Paz D.C., Evered A. et al. Pituitary response to thyrotropin releasing hormone in patients with chronic renal failure // Proc. Int. Cong. Nephrol. — 1975. — Vol. 5. — P. 889-993.

Ross R.J., Goodwin F.J., Houghton B.J., Boucher B.J. Alteration of pituitary-thyroid function in patients with chronic renal failure treated by haemodialysis or continuous ambulatory peritoneal dialysis // Ann. Clin. Biochem. — 1985. — Vol. 22. — P. 156-160.

Silverberg D.S., Ulan R.A., Fawcett D.M. et al. Effects of chronic hemodialysis on thyroid function in chronic renal failure // Can. Med. Assoc. J. — 1973. — Vol. 109. — P. 282-286.

Rodrigues M.C., Santos G.M., da Silva C.A. et al. Thyroid hormone transport is disturbed in erythrocytes from patients with chronic renal failure on hemodialysis // Ren. Fail. — 2004. — Vol. 26. — P. 461-466.

Zoccali C., Benedetto F., Mallamaci F. et al. Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease // J. Hypertens. — 2006. — Vol. 24. — P. 2039-2046.

Kang E.W., Nam J.Y., Yoo T.H. et al. Clinical implications of subclinical hypothyroidism in continuous ambulatory peritoneal dialysis patients // Am. J. Nephrol. — 2008. — Vol. 28. — P. 908-913.

Duntas L.H., Wartofsky L. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? // Thyroid. — 2007. — Vol. 17. — P. 1075-1084.

Iervasi G., Molinaro S., Landi P. et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients // Arch. Intern. Med. — 2007. — Vol. 167. — P. 1526-1532.

Zoccali C., Mallamaci F., Tripepi G. et al. Low triiodothyronine and survival in end-stage renal disease // Kidney International. — 2006. — Vol. 70. — P. 523-528.

Most read articles by the same author(s)